IV to PO transition may be a practical approach in gram-negative BSI. Patients with Gram-negative bacteremia who have HIV infection with CD4 <200 cells/mm3, multidrug-resistant infections, and respiratory tract sources of infection may not be ideal candidates for this approach. This evidence concerns the gene CD4 and HIV infectious disease.